04:19 PM EST, 01/07/2025 (MT Newswires) -- Jeffrey William Henderson, Director, on January 06, 2025, sold 10,000 shares in Halozyme Therapeutics ( HALO ) for $500,060. Following the Form 4 filing with the SEC, Henderson has control over a total of 43,611 shares of the company, with 43,611 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1159036/000141588925000995/xslF345X05/form4-01072025_090159.xml